Biotech Analyst Tewari holds a conference call with Chief Scientific Officer Quirk on October 10 at 1 pm hosted by Jefferies.Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SAGE:
- Sage Therapeutics participates in a conference call with Jefferies
- Sage Therapeutics management to meet with Oppenheimer
- Sage Therapeutics price target lowered to $24 from $25 at BofA
- Sage Therapeutics price target lowered to $22 from $25 at RBC Capital
- Sage Therapeutics price target raised to $20 from $19 at Mizuho